Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 14.82
-0.01 (-0.07%)
At close: Jul 17, 2025, 2:57 PM CST
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 5.81 billion as of July 18, 2025. Its market cap has increased by 52.00% in one year.
Market Cap
5.81B
Enterprise Value
5.03B
Revenue
761.64M
Ranking
n/a
PE Ratio
33.43
Stock Price
14.82
Market Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has increased from 5.31B to 5.81B, an increase of 9.47%. That is a compound annual growth rate of 3.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 5.81B | 50.02% |
| Dec 31, 2024 | 3.87B | -6.96% |
| Dec 29, 2023 | 4.16B | 8.12% |
| Dec 30, 2022 | 3.85B | -27.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 381.37B |
| Shenzhen Mindray Bio-Medical Electronics | 262.66B |
| WuXi AppTec | 225.41B |
| Sichuan Biokin Pharmaceutical | 120.65B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.55B |
| Aier Eye Hospital Group | 114.24B |
| Shanghai United Imaging Healthcare | 102.75B |
| Yunnan Baiyao Group Co.,Ltd | 99.76B |